A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma

Jantine W. P. M. van Baal*, Francesco Milana, Agnieszka M. Rygiel, Carine M. T. Sondermeijer, C. Arnold Spek, Jacques J. G. H. M. Bergman, Maikel P. Peppelenbosch, Kausilia K. Krishnadath

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    24 Citations (Scopus)


    Esophageal adenocarcinoma (EA) and esophageal squamous cell carcinoma (ESCC) are the two main types of esophageal cancer. Despite extensive research the exact molecular basis of these cancers is unclear. Therefore we evaluated the transcriptome of EA in comparison to non-dysplastic Barrett's esophagus (BE), the metaplastic epithelium that predisposes for EA, and compared the transcriptome of ESCC to normal esophageal squamous epithelium. For obtaining the transcriptomes tissue biopsies were used and serial analysis of gene expression (SAGE) was applied. Validation of results by RT-PCR and immunoblotting was performed using tissues of an additional 23 EA and ESCC patients. Over 58,000 tags were sequenced. Between EA and BE 1013, and between ESCC and normal squamous epithelium 1235 tags were significantly differentially expressed (P <0.05). The most up-regulated genes in EA compared to BE were SRY-box 4 and Lipocalin2, whereas the most down-regulated genes in EA were Trefoil factors and Annexin A 10. The most up-regulated genes in ESCC compared to normal squamous epithelium were BMP4, E-Cadherin and TFF3. The results could suggest that the BE expression profile is closer related to normal squamous esophagus then to EA. In addition, several uniquely expressed genes are identified.

    Original languageEnglish
    Pages (from-to)63-75
    Number of pages13
    JournalCellular oncology
    Issue number1
    Publication statusPublished - 2008


    • Barrett's esophagus
    • SAGE
    • gene expression profile
    • esophageal squamous cell carcinoma
    • esophageal adenocarcinoma
    • CANCER
    • P53

    Cite this